Published in Antimicrob Agents Chemother on November 26, 2012
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev (2014) 2.45
The evolving role of chemical synthesis in antibacterial drug discovery. Angew Chem Int Ed Engl (2014) 1.05
Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century. Microbiol Spectr (2016) 0.98
Mutation in ribosomal protein S5 leads to spectinomycin resistance in Neisseria gonorrhoeae. Front Microbiol (2013) 0.95
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012. BMC Infect Dis (2014) 0.92
Antibiotic resistance in prevalent bacterial and protozoan sexually transmitted infections. Indian J Sex Transm Dis (2015) 0.83
Genomic analyses of Neisseria gonorrhoeae reveal an association of the gonococcal genetic island with antimicrobial resistance. J Infect (2016) 0.82
Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives. Medchemcomm (2015) 0.82
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone. BMC Infect Dis (2014) 0.82
Proteomics of Neisseria gonorrhoeae: the treasure hunt for countermeasures against an old disease. Front Microbiol (2015) 0.81
Drug Resistance Mechanisms in Bacteria Causing Sexually Transmitted Diseases and Associated with Vaginosis. Front Microbiol (2016) 0.75
The Loop 2 Region of Ribosomal Protein uS5 Influences Spectinomycin Sensitivity, Translational Fidelity and Ribosome Biogenesis. Antimicrob Agents Chemother (2016) 0.75
Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep (2010) 14.85
Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature (1987) 8.96
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res (1984) 3.94
Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother (2011) 3.54
Cloning and nucleotide base sequence analysis of a spectinomycin adenyltransferase AAD(9) determinant from Enterococcus faecalis. Antimicrob Agents Chemother (1991) 3.13
Nucleotide sequence of a spectinomycin adenyltransferase AAD(9) determinant from Staphylococcus aureus and its relationship to AAD(3") (9). Mol Gen Genet (1985) 3.08
High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother (2011) 3.00
The emerging threat of untreatable gonococcal infection. N Engl J Med (2012) 2.85
Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med (1987) 2.70
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther (2009) 2.53
Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother (2009) 2.36
UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS (2011) 2.33
The structure of ribosomal protein S5 reveals sites of interaction with 16S rRNA. Nature (1992) 2.19
Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J Infect Chemother (2003) 2.00
Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother (2012) 1.95
Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill (2010) 1.94
The Gonococcus fights back: is this time a knock out? Sex Transm Infect (2010) 1.92
Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother (2009) 1.80
Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis (1995) 1.76
Ribosomal RNA and protein mutants resistant to spectinomycin. EMBO J (1990) 1.75
Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill (2011) 1.61
Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill (2011) 1.60
Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci (2011) 1.57
Spectinomycin resistance at site 1192 in 16S ribosomal RNA of E. coli: an analysis of three mutants. Biochimie (1987) 1.57
First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill (2011) 1.48
Update on the management of gonorrhea in adults in the United States. Clin Infect Dis (2007) 1.46
Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol (2009) 1.44
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? Antimicrob Agents Chemother (2012) 1.37
Spectinomycin interacts specifically with the residues G1064 and C1192 in 16S rRNA, thereby potentially freezing this molecule into an inactive conformation. Nucleic Acids Res (1994) 1.36
Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill (2012) 1.35
Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BC. Antimicrob Agents Chemother (2005) 1.24
Ribosomal proteins. XXVII. Localization of the amino acid exchanges in protein S5 from two Escherichia coli mutants resistant to spectinomycin. Mol Gen Genet (1972) 1.20
A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene. J Mol Diagn (2006) 1.20
The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J Antimicrob Chemother (2012) 1.17
An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J Antimicrob Chemother (2010) 1.17
Ribosomal proteins S5 and L6: high-resolution crystal structures and roles in protein synthesis and antibiotic resistance. J Mol Biol (1998) 1.16
Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA. Antimicrob Agents Chemother (2000) 1.12
Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important? Sex Transm Dis (1995) 1.07
A new mutation in 16S rRNA of Escherichia coli conferring spectinomycin resistance. Nucleic Acids Res (1995) 1.07
A novel single amino acid change in small subunit ribosomal protein S5 has profound effects on translational fidelity. RNA (2006) 1.06
Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother (2006) 1.06
In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea? Antimicrob Agents Chemother (2012) 0.98
The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill (2011) 0.97
Isolation of a gene encoding a novel spectinomycin phosphotransferase from Legionella pneumophila. Antimicrob Agents Chemother (1997) 0.95
Cephalosporin resistant Neisseria gonorrhoeae: time to consider gentamicin? Sex Transm Infect (2012) 0.93
Clinical validation of a real-time polymerase chain reaction detection of Neisseria gonorrheae porA pseudogene versus culture techniques. Sex Transm Dis (2008) 0.90
Novel spectinomycin/streptomycin resistance gene, aadA14, from Pasteurella multocida. Antimicrob Agents Chemother (2005) 0.89
Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis. Sex Transm Infect (2012) 0.89
Isolation of spectinomycin resistance mutations in the 16S rRNA of Salmonella enterica serovar Typhimurium and expression in Escherichia coli and Salmonella. Curr Microbiol (2002) 0.86
Mutations in 16S rRNA and ribosomal protein S5 associated with high-level spectinomycin resistance in Pasteurella multocida. Antimicrob Agents Chemother (2007) 0.86
The use of cephalosporins for gonorrhea: an update on the rising problem of resistance. Expert Opin Pharmacother (2012) 0.86
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med (2011) 11.09
[A man in his 30s with urethral discharge and dysuria]. Tidsskr Nor Laegeforen (2014) 3.67
Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother (2011) 3.54
High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother (2011) 3.00
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res (2013) 1.96
Five-day Azithromycin Treatment Regimen for Mycoplasma genitalium Infection Also Effectively Eradicates Chlamydia trachomatis. Acta Derm Venereol (2015) 1.50
[Reduce the use of one-dose azithromycin]. Tidsskr Nor Laegeforen (2011) 1.42
Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother (2013) 1.41
External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis (2011) 1.34
A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene. J Mol Diagn (2006) 1.20
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. J Clin Microbiol (2013) 1.15
A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae. MBio (2011) 1.14
Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins. Antimicrob Agents Chemother (2012) 1.01
In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea? Antimicrob Agents Chemother (2012) 0.98
Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis (2013) 0.98
Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands. Antimicrob Agents Chemother (2012) 0.98
HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway. J Acquir Immune Defic Syndr (2003) 0.97
First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea? Antimicrob Agents Chemother (2013) 0.96
Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011. BMC Infect Dis (2013) 0.95
The genital econiche: focus on microbiota and bacterial vaginosis. Ann N Y Acad Sci (2011) 0.94
Challenges with gonorrhea in the era of multi-drug and extensively drug resistance - are we on the right track? Expert Rev Anti Infect Ther (2014) 0.93
Clinical validation of a real-time polymerase chain reaction detection of Neisseria gonorrheae porA pseudogene versus culture techniques. Sex Transm Dis (2008) 0.90
Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012. BMC Infect Dis (2014) 0.90
Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae - the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin. BMC Infect Dis (2014) 0.89
Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally. Sex Transm Infect (2012) 0.89
Comparing urine samples and cervical swabs for Chlamydia testing in a female population by means of Strand Displacement Assay (SDA). BMC Womens Health (2010) 0.89
Genital ulcers as initial manifestation of Epstein-Barr virus infection: two new cases and a review of the literature. Acta Derm Venereol (2006) 0.89
Is an increase of MRSA in Oslo, Norway, associated with changed infection control policy? J Infect (2007) 0.86
Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children. Scand J Trauma Resusc Emerg Med (2011) 0.86
Tezosentan reduces the microvascular filtration coefficient in isolated lungs from rats subjected to cecum ligation and puncture. Crit Care (2005) 0.83
Short-term booster effect of diphtheria toxoid in initially long-term protected individuals. Vaccine (2005) 0.81
Antibiotic susceptibility of Neisseria gonorrhoeae in Arkhangelsk, Russia. Sex Transm Infect (2006) 0.81
A new automated method for isolation of Chlamydia trachomatis from urine eliminates inhibition and increases robustness for NAAT systems. J Microbiol Methods (2007) 0.80
Evaluation of Neisseria gonorrhoeae multiple-locus variable-number tandem-repeat analysis, N. gonorrhoeae Multiantigen sequence typing, and full-length porB gene sequence analysis for molecular epidemiological typing. J Clin Microbiol (2011) 0.80
[The Swedish Chlamydia mutant nvC trachomatis in Norway]. Tidsskr Nor Laegeforen (2010) 0.79
Antimicrobial susceptibility/resistance and molecular epidemiological characteristics of Neisseria gonorrhoeae in 2009 in Belarus. APMIS (2011) 0.79
A multidrug-resistant, methicillin-susceptible strain of Staphylococcus aureus from a neonatal intensive care unit in Oslo, Norway. Scand J Infect Dis (2010) 0.79
Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report. APMIS (2011) 0.78
Appropriate time for test-of-cure when diagnosing gonorrhoea with a nucleic acid amplification test. Acta Derm Venereol (2012) 0.77
Antidiphtheria antibody responses in patients and carriers of Corynebacterium diphtheriae in the Arkhangelsk region of Russia. Clin Vaccine Immunol (2006) 0.76
[Å. Haugstvedt & H. Moi reply]. Tidsskr Nor Laegeforen (2014) 0.75
[Sex and risk]. Tidsskr Nor Laegeforen (2014) 0.75
[Chlamydia infections in South Trondelag--treatment and follow-up]. Tidsskr Nor Laegeforen (2011) 0.75
[Vaginal samples best in genital chlamydia infections]. Tidsskr Nor Laegeforen (2012) 0.75
Trichomonas vaginalis infections are rare among young patients attending an STI clinic in Sweden. Acta Derm Venereol (2015) 0.75
Trichomonas vaginalis is Rare Among Women in Iceland. Acta Derm Venereol (2017) 0.75
[Mycoplasma genitalium--aetiological agent of sexually transmitted infection]. Tidsskr Nor Laegeforen (2007) 0.75
Tidsskr Nor Laegeforen (2017) 0.75
Overweight and Weight Gain Predict Psoriasis Development in a Population-based Cohort. Acta Derm Venereol (2017) 0.75
[Free HPV vaccine to young girls should be a human right in Norway!]. Tidsskr Nor Laegeforen (2009) 0.75
[The development of resistance must be monitored--gonococci as an example]. Tidsskr Nor Laegeforen (2014) 0.75
[Whooping cough in children]. Tidsskr Nor Laegeforen (2007) 0.75
Reliability of the Amplicor internal control to disclose false-negative Chlamydia trachomatis PCR results. J Microbiol Methods (2005) 0.75
[Invasive pneumoccal disease in children in Oslo 1998-2004]. Tidsskr Nor Laegeforen (2008) 0.75